Advertisement

Farewell from the Founding Editors of the JVS–Vascular Science

Open AccessPublished:May 17, 2022DOI:https://doi.org/10.1016/j.jvssci.2022.05.001
      Great things in business are never done by one person, they're done by a team of people.–Steve Jobs
      After 3 years as Editors of the JVS–Vascular Science (JVS-VS), we will be ending our term on June 30th, 2022, and passing the journal to the new Editor-in-Chief, Dr Alan Dardik, and his editorial team. As we reflect on the past 3 years, we have many fond memories, but the most vivid emotion is how honored we both are to have been the founding editors of an excellent open access, online-only, international, peer-reviewed journal on basic and translational vascular research. We have been honored to aid Dr Dardik and his outstanding and dedicated editorial team to launch JVS-VS, and to set up an informative and educational website, www.jvsvs.com.
      In just the third year of its existence, this journal has grown considerably, receiving 59 submissions in 2021 with an acceptance rate of 60%. It is already indexed in PubMed Central of the National Library of Medicine. JVS-VS, our “green” journal, is the fourth member of the JVS family. It is also part of the JVS portfolio of social media activities that includes monthly Editors’ Choice videos, press releases, article highlights, visual abstracts, the increasingly popular JVS journal clubs, JVS-VS Webinars, the JVS internship program, our CME program, and Audible Bleeding podcasts. Over the past 3 years, we transformed our editorial policies and increased the diversity of our editorial boards. JVS-VS is leading our journals with 33% women and under-represented minorities serving on its editorial board.
      None of this progress would have been possible without the expert and dedicated team of the JVS family. Great things, as Steve Jobs once said, are always done by a team of people. We feel so fortunate to have worked with the most talented and hard-working editorial staff, editorial board, assistant and associate editors, and with an excellent publisher, Elsevier. We express our gratitude to our sponsoring society, the Society for Vascular Surgery, for giving us the opportunity to serve as founding editors of JVS-VS, the fourth journal of JVS Publications. As we leave our positions, we wish good luck to incoming JVS-VS Editor-in-Chief Alan Dardik, MD, PhD, from Yale School of Medicine, and his team. We both feel very fortunate to have contributed to the founding and evolution of JVS-VS. The accomplishments have been so great that it makes saying goodbye so hard.